Although L-FABP levels appear less elevated in COVID-19 than in other pulmonary diseases [43], studies by Tantry et al. [22], and Katagiri et al. [44], in line with our findings, associated higher L-FABP levels with clinical events and prolonged hospitalization. The gene discussed is FABP1; the disease is lung disorder.